(Q42271121)

English

Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17-year follow-up

scientific article published on 5 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17-year follow-up (English)

1 reference

Europe PubMed Central

19 October 2017

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

G Nunnari

1

1 reference

Europe PubMed Central

19 October 2017

M R Pinzone

2

1 reference

Europe PubMed Central

19 October 2017

B Cacopardo

3

1 reference

Europe PubMed Central

19 October 2017

publication date

5 December 2012

1 reference

Europe PubMed Central

19 October 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

19 October 2017

20

1 reference

Europe PubMed Central

19 October 2017

e131-7

1 reference

Europe PubMed Central

19 October 2017

4

1 reference

Europe PubMed Central

19 October 2017

Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC).

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Therapy of hepatitis C: patients with normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Treatment of patients with chronic hepatitis C and normal ALT levels

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Clinical management of HCV carriers with normal aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Implication of normal liver enzymes in liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Chronic hepatitis C in patients with persistently normal alanine transaminase levels

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign?

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Natural history of initially mild chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Occurrence of hepatocellular carcinoma in an apparently 'healthy' HCV patient

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12029

21 January 2018

Identifiers

10.1111/JVH.12029

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42271121&oldid=1940766798"